MyAverix Finance
F · Healthcare
LISATA THERAP.INC.DL-001 (8NE)
Biotechnology
LISATA THERAP.INC.DL-001 (8NE) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 8NE
LISATA THERAP.INC.DL-001 (8NE) — FAQ
What is 8NE's P/E ratio?
The price-to-earnings (P/E) ratio for LISATA THERAP.INC.DL-001 (8NE) is 25.00 (data as of 2026-05-23).
Does LISATA THERAP.INC.DL-001 pay a dividend?
Dividend yield is not available in the current snapshot for LISATA THERAP.INC.DL-001 (8NE). Check the MyAverix Finance app for the latest dividend data.
What sector is LISATA THERAP.INC.DL-001 in?
LISATA THERAP.INC.DL-001 (8NE) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 8NE listed on?
8NE is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.